RxDoctor Payments Data

Jennifer Jennings

Family · McKenzie, TNNPI 1891249645

Payments from drug & device makers

$2,312in general payments, 2019–2025

Across 155 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$966
  • Takeda Pharmaceuticals U.S.A., Inc.$224
  • Lilly USA, LLC$196
  • Pfizer$138
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$117
  • Exact Sciences$102
  • plus $569 from 15 others

What the payments were for

  • Food & beverage$2,29999%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,312 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide102$138,920
VraylarCariprazine Hcl45$74,517
EliquisApixaban48$40,312
JardianceEmpagliflozin33$36,576
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$29,330
JanuviaSitagliptin Phosphate16$24,492
MounjaroTirzepatide18$19,737
EntrestoSacubitril/Valsartan27$19,214
FarxigaDapagliflozin Propanediol21$15,083
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$11,747
Repatha SureclickEvolocumab15$11,619
JanumetSitagliptin Phos/Metformin Hcl12$10,909
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen291$6,688
LinzessLinaclotide11$5,520
Dexlansoprazole DrDexlansoprazole26$5,248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$85$138,920102 claims
AbbVieVraylar, Linzess, Armour Thyroid$966$80,88167 claims
PfizerEliquis$138$40,31248 claims
Boehringer IngelheimJardiance$27$36,57633 claims
MerckJanuvia, Janumet$20$35,40028 claims
GSKTrelegy Ellipta, Breo Ellipta$12$34,07354 claims
AstraZenecaFarxiga, Breztri Aerosphere$15$26,83034 claims
Lilly USA, LLCMounjaro$196$19,73718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,706 family providers in Tennessee.

Other family in McKenzie

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →